Quick Facts

Chemical Name
Lysine-Proline-Valine
Also Known As
Alpha-MSH Fragment, KPV Tripeptide
Category
Immune System
Administration
Oral administration may be preferred for gut inflammation

What is KPV?

KPV is a tripeptide (Lysine-Proline-Valine) derived from the C-terminal end of alpha-melanocyte stimulating hormone (α-MSH). Despite being just three amino acids, it retains the anti-inflammatory properties of the parent hormone without the melanogenic (tanning) or hormonal effects. KPV has shown remarkable anti-inflammatory effects in research, particularly for gut inflammation and wound healing, working through mechanisms independent of melanocortin receptors.

How Does KPV Work?

Unlike other α-MSH derivatives, KPV's anti-inflammatory effects are largely independent of melanocortin receptors. It directly enters cells and inhibits the activation of NF-κB, a master regulator of inflammatory gene expression. KPV also inhibits the production of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), reduces inflammatory cell infiltration, and may directly interact with inflammatory pathways in the cell nucleus. This direct intracellular action makes it unique among anti-inflammatory peptides.

Research-Backed Benefits

Potent Anti-Inflammatory

Strong Evidence

Reduces inflammation through direct inhibition of NF-κB and inflammatory cytokines.

Gut Health Support

Moderate Evidence

Shows particular promise for inflammatory bowel conditions, reducing gut inflammation and promoting healing.

Wound Healing

Moderate Evidence

Accelerates wound healing while reducing inflammation and potentially scarring.

No Hormonal Effects

Strong Evidence

Retains anti-inflammatory benefits of α-MSH without affecting pigmentation or other hormonal pathways.

Dosage Guidelines

Disclaimer: This content is for educational purposes only. Peptides are research compounds not approved by the FDA for human use. Always consult with a qualified healthcare provider.

Typical Range
200-500 mcg orally or subcutaneously
Frequency
1-2 times daily
Duration
4-8 weeks typical protocols

May be effective orally for gut-targeted effects. Small size allows good tissue penetration.

Side Effects & Safety

  • Generally very well tolerated
  • Limited human safety data
  • No significant side effects reported in research
  • No melanogenic effects

Frequently Asked Questions

No, KPV has no melanogenic effects. It's the anti-inflammatory portion of α-MSH without the pigmentation-related sequences.
Research shows promise for inflammatory bowel conditions. KPV reduces gut inflammation through NF-κB inhibition and has shown benefits in experimental colitis models.
Both support gut health but through different mechanisms. BPC-157 promotes healing and angiogenesis; KPV primarily reduces inflammation through NF-κB inhibition. They may be complementary.
Yes, its small size (only 3 amino acids) allows for oral bioavailability, and it may be particularly effective orally for gut-targeted effects.

References

  1. Brzoska T, et al. "KPV anti-inflammatory effects." Endocr Rev, 2008. PMID: 18436705
  2. Kannengiesser K, et al. "KPV in experimental colitis." J Pharmacol Exp Ther, 2008. PMID: 18544677

Get the Complete KPV Research Protocol

Join 50,000+ researchers with instant access to our comprehensive peptide resource.

Continue Your Research